We and others have found that PLEKHA7 is primarily cytoplasmic in invasive lobular carcinoma, presumably due to E-cadherin loss [34], while in invasive ductal carcinoma, PLEKHA7 expression is predominantly lost. Here, PLEKHA7 is linked to invasive ductal breast carcinoma.